Cargando…

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk

Understanding the gene-specific risks for development of breast cancer will lead to improved clinical care for those carrying germline mutations in cancer predisposition genes. We sought to detail the spectrum of mutations and refine risk estimates for known and proposed breast cancer susceptibility...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slavin, Thomas P., Maxwell, Kara N., Lilyquist, Jenna, Vijai, Joseph, Neuhausen, Susan L., Hart, Steven N., Ravichandran, Vignesh, Thomas, Tinu, Maria, Ann, Villano, Danylo, Schrader, Kasmintan A., Moore, Raymond, Hu, Chunling, Wubbenhorst, Bradley, Wenz, Brandon M., D’Andrea, Kurt, Robson, Mark E., Peterlongo, Paolo, Bonanni, Bernardo, Ford, James M., Garber, Judy E., Domchek, Susan M., Szabo, Csilla, Offit, Kenneth, Nathanson, Katherine L., Weitzel, Jeffrey N., Couch, Fergus J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466608/ https://www.ncbi.nlm.nih.gov/pubmed/28649662 http://dx.doi.org/10.1038/s41523-017-0024-8

Ejemplares similares

Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
por: Slavin, Thomas P., et al.
Publicado: (2017)

Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing
por: Balmaña, Judith, et al.
Publicado: (2016)

Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition
por: Hughes, Elisha, et al.
Publicado: (2022)

Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2 negative patients with early onset breast cancer
por: Maxwell, Kara N., et al.
Publicado: (2014)

RAD51C Germline Mutations in Breast and Ovarian Cancer Cases from High-Risk Families
por: Clague, Jessica, et al.
Publicado: (2011)

Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes
por: Gallagher, Shannon, et al.
Publicado: (2020)

Assessment of SLX4 Mutations in Hereditary Breast Cancers
por: Shah, Sohela, et al.
Publicado: (2013)

COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration
por: Southey, Melissa C, et al.
Publicado: (2013)

Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model
por: Gallagher, Shannon, et al.
Publicado: (2021)

Hereditary diffuse gastric cancer: association with lobular breast cancer
por: Schrader, Kasmintan A., et al.
Publicado: (2007)

Founder populations and their uses for breast cancer genetics
por: Neuhausen, Susan L
Publicado: (2000)

The utility of ductal lavage in breast cancer detection and risk assessment
por: Domchek, Susan M
Publicado: (2002)

Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk
por: Hughes, Elisha, et al.
Publicado: (2020)

Breast cancer in young women
por: Gabriel, Courtney A, et al.
Publicado: (2010)

Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers
por: Neuhausen, Susan L, et al.
Publicado: (2009)

Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Rebbeck, Timothy R, et al.
Publicado: (2008)

Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
por: Peterlongo, Paolo, et al.
Publicado: (2021)

Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing
por: Hughes, Elisha, et al.
Publicado: (2021)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
por: Belhadj, Sami, et al.
Publicado: (2023)

The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk
por: Catucci, Irene, et al.
Publicado: (2016)

The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort
por: Hu, Chunling, et al.
Publicado: (2020)

Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients
por: Kwong, Ava, et al.
Publicado: (2020)

Severe Late Toxicity After Adjuvant Breast Radiotherapy in a Patient with a Germline Ataxia Telangiectasia Mutated Gene: Future Treatment Decisions
por: Dosani, Maryam, et al.
Publicado: (2017)

Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers
por: Wineland, Dylane, et al.
Publicado: (2023)

Whole exome sequencing and replication for breast cancer among Hispanic/Latino women identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer
por: Nierenberg, Jovia L., et al.
Publicado: (2023)

Common breast cancer risk variants in the post-COGS era: a comprehensive review
por: Maxwell, Kara N, et al.
Publicado: (2013)

Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer
por: Muranen, Taru A., et al.
Publicado: (2020)

Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia
por: Topka, Sabine, et al.
Publicado: (2015)

Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography
por: Keller, Brad M, et al.
Publicado: (2015)

Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels
por: Kwong, Ava, et al.
Publicado: (2017)

Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers
por: Friedman, Eitan, et al.
Publicado: (2006)

Molecular subtypes of triple-negative breast cancer in women of different race and ethnicity
por: Ding, Yuan Chun, et al.
Publicado: (2019)

Functional IGF1R variant predicts breast cancer risk in women with preeclampsia in California Teachers Study
por: Powell, Mark J., et al.
Publicado: (2017)

Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer
por: Yadav, Siddhartha, et al.
Publicado: (2020)

Using a Machine Learning Approach to Identify Low-Frequency and Rare FLG Alleles Associated with Remission of Atopic Dermatitis
por: Berna, Ronald, et al.
Publicado: (2021)

Keynote Address at the American Society of Breast Surgeons 18th Annual Meeting: Current and Future Application of Intraoperative Radiotherapy (IORT) in the Curative and Palliative Treatment of Breast Cancer
por: Wenz, Frederik
Publicado: (2017)

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers
por: Shah, Jennifer B., et al.
Publicado: (2022)

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
por: Shimelis, Hermela, et al.
Publicado: (2018)

Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics
por: Ding, Yuan Chun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pp3e9dej4aljfffavjevauu5uu